Impact of age and procedure on resource use for patients with ischemic heart disease

Kazuaki Kuwabara1, Yuichi Imanaka, Shinya Matsuda

  • 1Kyushu University, Graduate School of Medical Science, 3-1-1 Maidashi Higashiku, Fukuoka 812-8512, Japan. kazu228@basil.ocn.ne.jp

Insights

Age has a minor effect on healthcare costs for ischemic heart disease (IHD) patients compared to medical procedures. Procedures significantly impact healthcare spending more than patient age.

Area of Science:

  • Cardiovascular Medicine
  • Health Economics
  • Healthcare Management

Background:

  • Understanding the impact of patient demographics, such as age, on healthcare expenditures is crucial for resource allocation.
  • Previous studies have not adequately controlled for disease severity and specific medical procedures when assessing age-related healthcare costs.
  • Ischemic heart disease (IHD) represents a significant burden on healthcare systems, making it a relevant focus for cost analysis.

Purpose of the Study:

  • To examine the relationship between age and healthcare resource utilization in patients treated for ischemic heart disease (IHD).
  • To assess the independent effect of age on length of stay (LOS) and total charges (TC) in acute care settings.
  • To determine if age influences high outliers in LOS and TC, controlling for disease severity and procedures.

Main Methods:

  • Analysis of data from 19,874 IHD patients across 174 academic and community hospitals.
  • Categorization of patients into three age groups: under 65, 65-74, and 75 years or older.
  • Multivariate analysis to determine the independent impact of age on LOS, TC, and high outliers, considering procedures and illness severity.

Main Results:

  • The study included 39.6% of patients under 65, 36.1% between 65-74, and 24.3% aged 75+.
  • Treatment proportions for angina and non-medical interventions showed minor variations across age groups.
  • Procedures like coronary artery bypass graft surgery and percutaneous intracoronary intervention were significantly associated with higher total charges, particularly high outliers, more so than age.

Conclusions:

  • Age demonstrates a modest influence on healthcare resource use for IHD patients when compared to the impact of specific medical procedures.
  • Healthcare policy decisions regarding spending should prioritize the significant cost drivers associated with medical interventions.
  • The findings underscore the need to focus on procedural costs rather than solely on patient age when managing healthcare expenditures for IHD.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...